Psychopharmacological Treatment Status in Outpatients with Bipolar Disorder: A Clinical Survey in Germany
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
ObjectiveaaThe objective of this epidemiological study was to evaluate the current treatment status as well as the acceptance of medication and satisfaction with life in outpatients with bipolar disorder in Germany. MethodsaaData for this cross-sectional epidemiologic survey was collected between February 15th, 2006 and May 31st, 2006. Three hundreds six bipolar euthymic outpatients under routine treatment conditions were included in the study. Forty one practicing psychiatrists used a clinical interview to evaluate the current treatment status, acceptance of current medication, and current life satisfaction. ResultsaaThe majority of patients suffered from “pure” bipolar-II-disorder (50.6%), followed by 23.0% with “pure” bipolar-I-disorder. Apart from these patients, 12.9% of all participants had a history of mixed episodes and 5.6% a history of rapid cycling. Mean duration of bipolar disorder was 10.6 years. The majority of patients (54.3%) received psychopharmacological monotherapy. Combination therapy was administered in 45.9% of the patients, 39.3% receiving two agents, and 6.6% three agents. Antidepressants (64.1%) were the most common combination medications. Monotherapy was used preferably in bipolar-I- (62.7%) and bipolar-II-disorders (56.2%), combination therapy predominantly in patients with a history of mixed episodes (57.7%) and rapid cycling (55.0%). Half of the patients (49.2%) were able to hold an occupation. 84.2% of all patients were satisfied with their medication. Overall, patients evaluated their life satisfaction between “good” and “satisfactory” (2.69 according to German school grades where 1 is the highest and 6 the lowest mark). Patients receiving lithium, valproate or antidepressants as monotherapy rated above the mean, patients with combination therapy, carbamazepine monotherapy or medications summarized as “others” rated below the mean. ConclusionaaMost of the German outpatients received a pharmacotherapy that is recommended in the guidelines of bipolar disorder. The use of (atypical) antipsychotics was low. Conversely, the incidence of treatment with tricyclic antidepressants (not guideline compatible), was observed to be relatively high. Irrespective of their medication, in Germany patients with bipolar disorder show a high acceptance of their pharmacotherapy, and rate their life satisfaction as high. Nonetheless, half of the evaluated patients were not able to pursue a profession. Besides the disease age, gender and family life e.g., child care may also play a confounding role regarding the unemployment statistics
Abstract
ObjectiveaaThe objective of this epidemiological study was to evaluate the current treatment status as well as the acceptance of medication and satisfaction with life in outpatients with bipolar disorder in Germany. MethodsaaData for this cross-sectional epidemiologic survey was collected between February 15th, 2006 and May 31st, 2006. Three hundreds six bipolar euthymic outpatients under routine treatment conditions were included in the study. Forty one practicing psychiatrists used a clinical interview to evaluate the current treatment status, acceptance of current medication, and current life satisfaction. ResultsaaThe majority of patients suffered from “pure” bipolar-II-disorder (50.6%), followed by 23.0% with “pure” bipolar-I-disorder. Apart from these patients, 12.9% of all participants had a history of mixed episodes and 5.6% a history of rapid cycling. Mean duration of bipolar disorder was 10.6 years. The majority of patients (54.3%) received psychopharmacological monotherapy. Combination therapy was administered in 45.9% of the patients, 39.3% receiving two agents, and 6.6% three agents. Antidepressants (64.1%) were the most common combination medications. Monotherapy was used preferably in bipolar-I- (62.7%) and bipolar-II-disorders (56.2%), combination therapy predominantly in patients with a history of mixed episodes (57.7%) and rapid cycling (55.0%). Half of the patients (49.2%) were able to hold an occupation. 84.2% of all patients were satisfied with their medication. Overall, patients evaluated their life satisfaction between “good” and “satisfactory” (2.69 according to German school grades where 1 is the highest and 6 the lowest mark). Patients receiving lithium, valproate or antidepressants as monotherapy rated above the mean, patients with combination therapy, carbamazepine monotherapy or medications summarized as “others” rated below the mean. ConclusionaaMost of the German outpatients received a pharmacotherapy that is recommended in the guidelines of bipolar disorder. The use of (atypical) antipsychotics was low. Conversely, the incidence of treatment with tricyclic antidepressants (not guideline compatible), was observed to be relatively high. Irrespective of their medication, in Germany patients with bipolar disorder show a high acceptance of their pharmacotherapy, and rate their life satisfaction as high. Nonetheless, half of the evaluated patients were not able to pursue a profession. Besides the disease age, gender and family life e.g., child care may also play a confounding role regarding the unemployment statistics
참고문헌 (29)
- Angst J, "Historical perspectives and natural history of bipolar disorder", Biol Psychiatry, 48, pp.445~457 (2000)
- Sharma R, "Mortality in affective disorder", J Affect Disord, 31, pp.91~96 (1994)
- Tohen M, "Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features", Am J Psychiatry, 157, pp.220~228 (2000)
- Kupka RW, "Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder", Bipolar Disord, 9, pp.531~535 (2007)
- Judd LL, "The long-term natural history of the weekly symptomatic status of bipolar I disorder", Arch Gen Psychiatry, 59, pp.530~537 (2002)
- "The World Health Report 2000-He-alth Systems: Improving Performance"[URL]
- Yatham LN, "Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007", Bipolar Disord, 8, pp.721~739 (2006)
- "Practice guideline for the treatment of patients with bipolar disorder (revision)", Am J Psychiatry, 159, pp.1~50 (2002)
- Baldessarini RJ, "Factors associated with treatment nonadherence among US bipolar disorder patients", Hum Psychopharmacol, 23, pp.95~105 (2008)
- Miller DS, "Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania", J Clin Psychiatry, 62, pp.975~980 (2001)
- Sachs GS, "Effectiveness of adjunctive antidepressant treatment for bipolar depression", N Engl J Med, 356, pp.1711~1722 (2007)
- Leverich GS, "Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers", Am J Psychiatry, 163, pp.232~239 (2006)
- Baldessarini RJ, "Enhancing treatment with psychotropic medicines", Bull Menninger Clin, 58, pp.224~241 (1994)
- Keck PE Jr, "Compliance with maintenance treatment in bipolar disorder", Psychopharmacol Bull, 33, pp.87~91 (1997)
- Sajatovic M, "Treatment adherence with antipsychotic medications in bipolar disorder", Bipolar Disord, 8, pp.232~241 (2006)
- Lin D, "Polytherapy in bipolar disorder", CNS Drugs, 20, pp.29~42 (2006)
- Baethge C, "Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients", J Clin Psychiatry, 66, pp.174~182 (2005)
- Busch AB, "Changes in the quality of care for bipolar I disorder during the 1990s", Psychiatr Serv, 58, pp.27~33 (2007)
- Eaddy M, "Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population", Clin Ther, 27, pp.263~272 (2005)
- Gianfrancesco FD, "Antipsychotic treatment adherence and associated mental health care use among individuals with bipolar disorder", Clin Ther, 30, pp.1358~1374 (2008)
- Darling CA, "Bipolar disorder: medication adherence and life contentment", Arch Psychiatr Nurs, 22, pp.113~126 (2008)
- Goossens PJ, "Self-reported psychopathological symptoms and quality of life in outpatients with bipolar disorder", Perspect Psychiatr Care, 44, pp.275~284 (2008)
- Yen CF, "Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission", Bipolar Disord, 10, pp.617~624 (2008)
- Baldessarini R, "Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence", Psychiatr Serv, 59, pp.1175~1183 (2008)
- Freeman TW, "A double-blind comparison of valproate and lithium in the treatment of acute mania", Am J Psychiatry, 149, pp.108~111 (1992)
- Calabrese JR, "Rapid cycling bipolar disorder and its treatment with valproate", Can J Psychiatry, 38, pp.S57~S61 (1993)
- Altshuler L, "Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up", American Journal of Psychiatry, 160, pp.1252~1262 (2003)
- "The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties", Soc Sci Med, 46, pp.1569~1585 (1998)
- Ardinell WA, "Symptom Checklist 90; SCL-90" (2005), Harcourt Assessment B V